Pekka Kurki
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research 25
- Rheumatoid Arthritis Research and Therapies 17
- Immunology top 2%
- Biosimilars and Bioanalytical Methods 13
- T-cell and B-cell Immunology 9
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 8
-
- Monoclonal and Polyclonal Antibodies Research 37
- Cell Biology top 2%
- Skin and Cellular Biology Research 10
-
- Pharmaceutical Economics and Policy 9
- Co-authors
- Eng M. TanIsmo VirtanenKenji OgataEwert LinderMartin VanderlaanJoe W. GrayFrank DolbeareElena Wolff‐Holz
- Journals
- Scandinavian Journal of Rheumatology (6 papers)Scandinavian Journal of Immunology (5 papers)Generics and Biosimilars Initiative Journal (5 papers)
- Partner nations
- FinlandUnited StatesGermany
In The Last Decade
Pekka Kurki
94 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 129
- Rheumatology 1.1k
- Immunology 1.1k
- Immunology and Allergy 280
- Radiology, Nuclear Medicine and Imaging 930
- Cell Biology 556
Countries citing papers authored by Pekka Kurki
This map shows the geographic impact of Pekka Kurki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pekka Kurki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pekka Kurki more than expected).
Fields of papers citing papers by Pekka Kurki
This network shows the impact of papers produced by Pekka Kurki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pekka Kurki. The network helps show where Pekka Kurki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pekka Kurki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2021 | 57 | |
| 3 | 2019 | 9 | |
| 4 | 2018 | 7 | |
| 5 | 2016 | 12 | |
| 6 | 2005 | 21 | |
| 7 | 2002 | 25 | |
| 8 | 2001 | 1 | |
| 9 | 2001 | 64 | |
| 10 | 1998 | 32 | |
| 11 | 1998 | 51 | |
| 12 | 1998 | 44 | |
| 13 | 1997 | 45 | |
| 14 | Anti-RA 33 as a marker antibody of rheumatoid arthritis in a Finnish population. | 1993 | 8 |
| 15 | 1992 | 39 | |
| 16 | 1991 | 19 | |
| 17 | 1991 | 65 | |
| 18 | 1990 | 18 | |
| 19 | 1990 | 31 | |
| 20 | 1980 | 34 |
About Pekka Kurki
Pekka Kurki is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 95 papers that have together received 4.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (37 papers), Systemic Lupus Erythematosus Research (25 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Biosimilars and Bioanalytical Methods (13 papers), Skin and Cellular Biology Research (10 papers), Pharmaceutical Economics and Policy (9 papers), T-cell and B-cell Immunology (9 papers) and Cell Adhesion Molecules Research (8 papers). The work is most often cited by research in Rheumatology (1.1k citations), Immunology (1.1k citations) and Immunology and Allergy (280 citations). Pekka Kurki has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Eng M. Tan, Ismo Virtanen, Kenji Ogata, Ewert Linder, Martin Vanderlaan, Joe W. Gray, Frank Dolbeare, Elena Wolff‐Holz, S Stenman and T. Helve. Their work appears in journals such as Scandinavian Journal of Rheumatology, Scandinavian Journal of Immunology, Generics and Biosimilars Initiative Journal, Journal of Immunological Methods and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.